Acquired sideroblastic anaemia associated with penicillamine therapy for rheumatoid arthritis.
作者信息
Kandola L, Swannell A J, Hunter A
出版信息
Ann Rheum Dis. 1995 Jun;54(6):529-30. doi: 10.1136/ard.54.6.529-b.
Abstract
摘要
相似文献
1
Acquired sideroblastic anaemia associated with penicillamine therapy for rheumatoid arthritis.与青霉胺治疗类风湿关节炎相关的获得性铁粒幼细胞贫血。
Ann Rheum Dis. 1995 Jun;54(6):529-30. doi: 10.1136/ard.54.6.529-b.
2
Acquired sideroblastic anaemia after aplastic anaemia caused by D-penicillamine therapy for rheumatoid arthritis.类风湿关节炎患者接受青霉胺治疗后再生障碍性贫血继发获得性铁粒幼细胞贫血。
Ann Rheum Dis. 1987 Feb;46(2):156-8. doi: 10.1136/ard.46.2.156.
3
Sideroblastic anemia associated with penicillamine therapy.与青霉胺治疗相关的铁粒幼细胞性贫血。
Arch Intern Med. 1981 Nov;141(12):1713-4.
4
Fatal aplastic anaemia and liver toxicity caused by D-penicillamine treatment of rheumatoid arthritis.青霉胺治疗类风湿关节炎导致的致命性再生障碍性贫血和肝毒性。
Ann Rheum Dis. 1989 Jul;48(7):609-10. doi: 10.1136/ard.48.7.609.
5
Acquired sideroblastic anaemia during treatment of Wilson's disease with triethylene tetramine dihydrochloride.在使用二盐酸三乙撑四胺治疗威尔逊病期间获得性铁粒幼细胞贫血。
Br J Haematol. 1993 Jan;83(1):166-8. doi: 10.1111/j.1365-2141.1993.tb04648.x.
6
Thrombotic thrombocytopenic purpura during penicillamine therapy in rheumatoid arthritis.类风湿关节炎患者青霉胺治疗期间发生血栓性血小板减少性紫癜。
Arch Intern Med. 1983 Jul;143(7):1487-8.
7
Hepatotoxicity associated with use of D-penicillamine in rheumatoid arthritis.类风湿关节炎患者使用青霉胺相关的肝毒性。
Ann Rheum Dis. 1980 Apr;39(2):152-4. doi: 10.1136/ard.39.2.152.
8
Myasthenia associated with D-penicillamine therapy in rheumatoid arthritis.类风湿关节炎中与青霉胺治疗相关的肌无力。
Proc R Soc Med. 1977;70 Suppl 3(Suppl 3):114-7. doi: 10.1177/00359157770700S335.
9
[Myasthenia as a complication of D-penicillamine therapy of rheumatoid arthritis].[重症肌无力作为类风湿关节炎青霉胺治疗的并发症]
Ter Arkh. 1987;59(4):139-41.
10
Acquired sideroblastic anaemia following progesterone therapy.
Br J Haematol. 1994 Aug;87(4):859-62. doi: 10.1111/j.1365-2141.1994.tb06753.x.
引用本文的文献
1
Drug-induced hematologic syndromes.药物性血液学综合征
Adv Hematol. 2009;2009:495863. doi: 10.1155/2009/495863. Epub 2009 Jul 7.
本文引用的文献
1
ANTITUBERCULOUS DRUGS AND SIDEROBLASTIC ANAEMIA.抗结核药物与铁粒幼细胞性贫血
Br J Haematol. 1965 Jan;11:92-8. doi: 10.1111/j.1365-2141.1965.tb00088.x.
2
RHEUMATOID ARTHRITIS WITH ARTERITIS; REPORT OF A CASE TREATED WITH PENICILLAMINE.类风湿关节炎合并动脉炎；青霉胺治疗病例报告
Ann Intern Med. 1964 Sep;61:556-63. doi: 10.7326/0003-4819-61-3-556.
3
Sideroblastic anemia associated with penicillamine therapy.与青霉胺治疗相关的铁粒幼细胞性贫血。
Arch Intern Med. 1981 Nov;141(12):1713-4.
4
Proposals for the classification of the myelodysplastic syndromes.骨髓增生异常综合征的分类建议。
Br J Haematol. 1982 Jun;51(2):189-99.
5
Reversible megaloblastic and sideroblastic marrow abnormalities in alcoholic patients.酒精性患者中可逆性巨幼细胞性和环形铁粒幼细胞性骨髓异常
Br J Haematol. 1969 Jan-Feb;16(1):87-101. doi: 10.1111/j.1365-2141.1969.tb00381.x.
6
Acquired sideroblastic anaemia after aplastic anaemia caused by D-penicillamine therapy for rheumatoid arthritis.类风湿关节炎患者接受青霉胺治疗后再生障碍性贫血继发获得性铁粒幼细胞贫血。
Ann Rheum Dis. 1987 Feb;46(2):156-8. doi: 10.1136/ard.46.2.156.
7
Toxicity of D-penicillamine in rheumatoid arthritis. A report of 63 patients including two with aplastic anemia and one with the nephrotic syndrome.
Am J Med. 1978 Jan;64(1):114-20. doi: 10.1016/0002-9343(78)90186-9.
8
Myelotoxicity of D-penicillamine.青霉胺的骨髓毒性
Ann Rheum Dis. 1979 Jun;38(3):232-6. doi: 10.1136/ard.38.3.232.
9
Penicillamine in rheumatoid arthritis: adverse effects.
Scand J Rheumatol Suppl. 1979(28):94-9. doi: 10.3109/03009747909108247.
Zotero 插件